标题
Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-08-23
DOI
10.1038/s41598-017-09470-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial
- (2017) Victoria K. Snowdon et al. PLOS MEDICINE
- Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
- (2017) Hooi Hooi Ng et al. Scientific Reports
- Label-free fluorescence lifetime and second harmonic generation imaging microscopy improves quantification of experimental renal fibrosis
- (2016) Suman Ranjit et al. KIDNEY INTERNATIONAL
- Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
- (2016) Vivette D. D'Agati et al. Nature Reviews Nephrology
- Exercise Training Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Stenosis
- (2016) Brunno Lemes de Melo et al. Frontiers in Physiology
- Regular exercise improves cardiac contractile activation by modulating MHC isoforms and SERCA activity in orchidectomized rats
- (2015) Pavarana Vutthasathien et al. JOURNAL OF APPLIED PHYSIOLOGY
- Imaging Fibrosis and Separating Collagens using Second Harmonic Generation and Phasor Approach to Fluorescence Lifetime Imaging
- (2015) Suman Ranjit et al. Scientific Reports
- Serelaxin: A Novel Therapy for Acute Heart Failure with a Range of Hemodynamic and Non-Hemodynamic Actions
- (2014) Javier Díez American Journal of Cardiovascular Drugs
- Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
- (2014) Chrishan S. Samuel et al. HYPERTENSION
- HMG-CoA Reductase Inhibitors in Chronic Kidney Disease
- (2013) A. Olyaei et al. American Journal of Cardiovascular Drugs
- A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
- (2013) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
- (2012) John R Teerlink et al. LANCET
- Echocardiographic Parameters are Independently Associated with Rate of Renal Function Decline and Progression to Dialysis in Patients with Chronic Kidney Disease
- (2011) S.-C. Chen et al. Clinical Journal of the American Society of Nephrology
- The Role of Nitric Oxide on Endothelial Function
- (2011) Dimitris Tousoulis et al. Current Vascular Pharmacology
- Relaxin regulates vascular wall remodeling and passive mechanical properties in mice
- (2011) Dan O. Debrah et al. JOURNAL OF APPLIED PHYSIOLOGY
- Targeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor-β
- (2010) Amanda J Edgley et al. Cardiovascular Therapeutics
- Relaxin in Human Pregnancy
- (2009) Laura T. Goldsmith et al. Annals of the New York Academy of Sciences
- Fluid overload in acute heart failure - Re-distribution and other mechanisms beyond fluid accumulation
- (2008) Gad Cotter et al. EUROPEAN JOURNAL OF HEART FAILURE
- Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
- (2008) Ishanee Mookerjee et al. FASEB JOURNAL
- Relaxin, a pleiotropic vasodilator for the treatment of heart failure
- (2008) Sam L. Teichman et al. HEART FAILURE REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search